title: Olmesartan-Associated Enteropathy: A Review of Clinical and Histologic Findings.
abstract: Olmesartan is an antihypertensive medication belonging to the angiotensin II receptor blocker class of drugs that has recently been associated with severe enteropathy. Olmesartan-associated enteropathy is uncommon and may be difficult to recognize because of its clinical and histologic similarities to other clinical entities, including celiac sprue and autoimmune enteropathy. The purpose of this article is to review the clinical and histologic findings of olmesartan-associated enteropathy that have been reported in the literature and to discuss clinical entities to consider in the differential diagnosis of olmesartan-associated enteropathy.
authors.affiliation: From the Department of Pathology, University of Michigan, Ann Arbor.
authors.forename: Eun-Young Karen
authors.initials: EY
authors.lastname: Choi
authors.forename: Barbara J
authors.initials: BJ
authors.lastname: McKenna
mesh_terms: D000959:Antihypertensive Agents / Q000009:adverse effects; D002446:Celiac Disease / Q000175:diagnosis; D003937:Diagnosis, Differential; D003967:Diarrhea / Q000139:chemically induced / Q000175:diagnosis / Q000628:therapy; D041981:Gastrointestinal Tract / Q000187:drug effects / Q000473:pathology*; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D007410:Intestinal Diseases / Q000139:chemically induced / Q000175:diagnosis* / Q000628:therapy; D016884:Polyendocrinopathies, Autoimmune / Q000175:diagnosis; D013777:Tetrazoles / Q000009:adverse effects*; D028761:Withholding Treatment
chemical_list: D000959:Antihypertensive Agents; D007093:Imidazoles; D013777:Tetrazoles; C437965:olmesartan